Factors affecting guardians' decision‐making regarding the SARS‐CoV‐2 vaccine

Author:

Korematsu Seigo12ORCID,Mine Mahito13,Kobayashi Toshihiro14,Hara Tomokuni15,Oyama Shoichi16,Tanaka Shuhou17,Kobayashi Noriaki18,Kawano Yutaka1,Suganuma Eisuke19,Furuichi Mihoko19,Momoki Toshiro110,Minakuchi Junichi111

Affiliation:

1. Sai‐no‐Kuni Vaccination Promotion Council Saitama Japan

2. Department of Pediatrics, Saitama Medical Center Saitama Medical University Kawagoe Japan

3. Mine Pediatrics Saitama Japan

4. Kobayashi Kid Clinic Kumagaya Saitama Japan

5. Hara Kodomo Clinic Tokorozawa Japan

6. Department of Pediatrics Saiseikai Kawaguchi General Hospital Kawaguchi Saitama Japan

7. Clinic for Babies & Children Kawaguchi Saitama Japan

8. Kobayashi Children's Clinic Kawagoe Saitama Japan

9. Division of Infectious Diseases and Immunology, Allergy Saitama Children's Medical Center Saitama Japan

10. Momoki Children's Clinic Koshigaya Saitama Japan

11. Minakuchi Children's Clinic Tsurugashima Saitama Japan

Abstract

AbstractBackgroundIn Japan, the vaccination rate against the SARS‐CoV‐2 vaccine for children was low. Therefore, in this study we investigated the factors influencing guardians' decision‐making regarding vaccination of their children.MethodsFrom November 1, 2022 to March 31, 2023, pediatric clinics, departments, and midwifery clinics in Saitama Prefecture requested guardians of children under the age of 15 to complete an online questionnaire.ResultsResponses were obtained from 894 guardians of children aged 6 months to 15 years; 142 had had one of their children vaccinated at least once and 629 had not had any of their children vaccinated. Among guardians who had not had any of their children vaccinated, “the Age of children” was significantly younger (p < 0.001) and “Prevalence” (p < 0.001), “Free vaccination” (p < 0.001), and “Intentions of national and local governments” (p = 0.005) were selected as reasons significantly less frequently in comparison to guardians who had vaccinated their children. “Japanese adverse reactions” (p < 0.001), “Japanese effectiveness” (p < 0.001), “Adverse reactions” (p < 0.001), “History of adverse reactions” (p < 0.001), and “Reputation of friends” (p = 0.006) were selected significantly more frequently by guardians who had not had any of their children vaccinated.ConclusionsGuardians who had had one of their children vaccinated at least once emphasized the importance of prevalence and free vaccination. On the other hand, guardians who had not had any of their children vaccinated placed particular importance on adverse reactions and the Japanese data on effectiveness. To guide the decision‐making of guardians, it is necessary to quickly collect and publish data on adverse reactions and effectiveness, particularly in Japanese individuals, so that citizens can decide whether to vaccinate themselves and their children.

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Reference22 articles.

1. World Health Organization.[homepage on the internet]. WHO Coronavirus (COVID‐19) Dashboard.2023Available from:https://covid19.who.int/?adgroupsurvey=%7badgroupsurvey%7d&gclid=EAIaIQobChMI‐LPG9Y37_AIV1ttMAh3w7QcZEAAYASABEgKQsvD_BwE

2. Ministry of Health Labour and Welfare.[homepage on the internet]. Visualizing the data: information on COVID‐19 infections.2023Available from:https://covid19.mhlw.go.jp/en/

3. The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan

4. Japan Pediatric Society.[homepage on the internet]. COVID‐19‐related information.2023(in Japanese). Available from:https://www.jpeds.or.jp/modules/activity/index.php?content_id=333

5. Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3